Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SANA

Sana Biotechnology, Inc.

CIK 0001770121 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.93
↓ 0.05 (-1.26%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.09B
P/E Ratio
-4.52
EPS
-0.96
Dividend Yield
Not covered
52W Position
34%
Beta
2.47

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
9.17
P/S
Not covered
EV/Revenue
Not covered
ROE
-202.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 34%
$2.61$6.55

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$244.17M
Total Assets
$416.89M
Free Cash Flow
-$144.77M

Recent news